Related Experiment Video
Updated: Jun 19, 2026
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs: tools for cancer diagnostics
T Paranjape1, F J Slack, J B Weidhaas
1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut, 06520, USA.
Abstract:
Recently, a novel class of global gene regulators called microRNAs (miRNAs), were identified in both plants and animals. MiRNAs can reduce protein levels of their target genes with a minor impact on the target genes' mRNAs. Accumulating evidence demonstrates the importance of miRNAs in cancer. MiRNAs that are overexpressed in cancer may function as oncogenes, and miRNAs with tumour suppressor activity in normal tissue may be downregulated in cancer. Although major advances have been achieved in our understanding of cancer biology, as well as in the development of new targeted therapies, the progress in developing improved early diagnosis and screening tests has been inadequate. This results in most cancers being diagnosed in advanced stages, delaying timely treatment and leading to poor outcomes. There is intense research seeking specific molecular changes that are able to identify patients with early cancer or precursor lesions. MiRNA expression data in various cancers demonstrate that cancer cells have different miRNA profiles compared with normal cells, thus underscoring the tremendous diagnostic and therapeutic potential of miRNAs in cancer. These unique properties of miRNAs make them extremely useful potential agents for clinical diagnostics as well as in personalised care for individual patients in the future.
Insights
MicroRNAs (miRNAs) are gene regulators crucial in cancer. Their distinct expression profiles in cancer cells offer significant potential for early cancer diagnosis and personalized treatment strategies.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are emerging as critical global gene regulators in both plants and animals.
- MiRNAs function by reducing target gene protein levels with minimal impact on messenger RNA (mRNA).
- Evidence increasingly highlights the significant role of miRNAs in the development and progression of various cancers.
Purpose of the Study:
- To explore the diagnostic and therapeutic potential of microRNAs (miRNAs) in oncology.
- To address the inadequacy in early cancer diagnosis and screening methods.
- To investigate unique miRNA expression profiles for identifying early-stage cancers or precursor lesions.
Main Methods:
- Analysis of miRNA expression data across different cancer types.
- Comparison of miRNA profiles between cancerous and normal cells.
- Review of existing literature on miRNA functions in cancer biology.
Main Results:
- Cancer cells exhibit distinct miRNA expression profiles compared to normal cells.
- Overexpressed miRNAs can act as oncogenes, while downregulated tumor suppressor miRNAs are observed in cancer.
- MiRNA dysregulation is a hallmark of cancer, indicating its involvement in disease pathology.
Conclusions:
- MicroRNAs (miRNAs) hold immense potential as biomarkers for early cancer detection and screening.
- Unique miRNA signatures in cancer patients can facilitate personalized treatment approaches.
- Further research into miRNAs is vital for advancing cancer diagnostics and patient care.
